- Home
- ANTX vs FLC Comparison
ANTX vs FLC Comparison
Compare ANTX & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANTX | FLC |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.7M | 179.0M |
| IPO Year | 2022 | 2003 |
Fundamental Metrics
Financial Performance| Metric | ANTX | FLC |
|---|---|---|
| Price | $5.10 | $16.70 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 239.6K | 19.3K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $15.89 |
| 52 Week High | $6.91 | $18.09 |
Technical Indicators
Market Signals| Indicator | ANTX | FLC |
|---|---|---|
| Relative Strength Index (RSI) | 61.53 | 44.50 |
| Support Level | $1.06 | $16.63 |
| Resistance Level | $6.91 | $17.00 |
| Average True Range (ATR) | 0.40 | 0.14 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 84.25 | 41.03 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.